GAIA BioMaterials, a leader in biodegradable and compostable bioplastics, has received final approval for a European patent on its PLA-free film extrusion materials. The patent, filed in 2020, protects a new line of compounds that replace traditional polylactic acid with a blend of biodegradable polymers and minerals.
These innovative materials are already in use for products such as carrier bags, fruit and vegetable bags, waste bags, and medical aprons. Several additional applications are under development, demonstrating GAIA’s commitment to expanding sustainable packaging options.
Peter Stenström, CEO of GAIA, expressed his satisfaction with the patent approval. He said, “We are very pleased with the final confirmation for this patent. I know the effort that has gone into it; it reflects the people in our R&D department, and the work they are capable of.”
Niklas Rosenkvist, Sales Director, added, “Our customers have responded really well to the new materials developed under the patent. It shows that we as an organization not only are capable of identifying the needs in the market, but also deliver on them.”
Konrad Rosén, R&D Director, highlighted the strategic significance of the patent. “Having the patent finally confirmed in Europe, we know that our new R&D platform and patent strategy is working. We can now continue our efforts into developing the next generation of leading biodegradable and compostable bioplastics,” he said.
Founded in 2015 and based in Helsingborg, Sweden, GAIA Biomaterials produces Biodolomer, a compostable material with qualities similar to plastic but without its environmental drawbacks. The company’s innovations aim to create sustainable solutions that leave no microplastics or pollution behind.
The post GAIA BioMaterials secures European patent for PLA-free bioplastic films appeared first on World Bio Market Insights.
